Use of human ultralente as the basal insulin component in treatment of patients with IDDM
- 31 July 1991
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 12 (3) , 187-192
- https://doi.org/10.1016/0168-8227(91)90076-p
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Comparison of Human Ultralente‐and Lente‐based Twice‐daily Injection RegimensDiabetic Medicine, 1989
- Human, Porcine and Bovine Ultralente Insulin: Subcutaneous Administration in Normal ManDiabetic Medicine, 1986
- Use of Beef Ultralente for Basal Insulin Delivery: Plasma Insulin Concentrations After Chronic Ultralente Administration in Patients with IDDMDiabetes Care, 1986
- Human insulin.BMJ, 1986
- The Subcutaneous Absorption of Human and Bovine Ultralente Insulin FormulationsDiabetic Medicine, 1985
- A Practical Guide to Basal and Prandial Insulin TherapyDiabetic Medicine, 1985
- Human ultralente insulin.BMJ, 1984
- Ultralente Based Insulin Regimens—Clinical Applications, Advantages and DisadvantagesActa Medica Scandinavica, 1983
- Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatientsActa Diabetologica, 1981
- Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin TherapyNew England Journal of Medicine, 1980